The clinical landscape for vestibular migraine, a condition that bridges the gap between neurology and otology, is undergoing a significant transformation as researchers seek more objective methods to quantify patient symptoms. A recent study spearheaded by a multidisciplinary team at the University of California, San Francisco (UCSF), has provided groundbreaking insights into "visual vertigo"—the debilitating dizziness and discomfort triggered by movement or complex visual environments. Presented at the American Neurotology Society’s Combined Sections Meeting in April 2026, this research marks a pivotal step toward standardizing the way clinicians assess and treat one of the most common yet misunderstood vestibular disorders.
The study, which earned the prestigious VeDA/ANS Travel Award, addresses a long-standing challenge in the field of neurotology: the reliance on subjective patient reporting for symptoms that are often difficult to describe. For individuals living with vestibular migraine (VM), everyday tasks such as navigating a crowded grocery store, scrolling through a smartphone, or watching an action movie can become insurmountable hurdles. By utilizing a controlled environment and a standardized set of visual stimuli, the UCSF team has demonstrated that these subjective experiences can be measured with clinical precision, paving the way for improved diagnostic tools and personalized therapeutic interventions.
Understanding the Clinical Context of Vestibular Migraine
Vestibular migraine is currently recognized as the most common cause of spontaneous episodic vertigo. Despite its prevalence, it remains a complex diagnosis, often overlapping with other conditions such as Meniere’s disease or Persistent Postural-Perceptual Dizziness (PPPD). Unlike traditional migraines, which are primarily characterized by intense headaches, VM is defined by vestibular symptoms—including vertigo, dizziness, and balance instability—that are linked to migraine pathophysiology.
A hallmark of VM is hypersensitivity to sensory input. While light (photophobia) and sound (phonophobia) are well-documented triggers, "visual vertigo" or visual-vestibular mismatch is equally pervasive. Patients often report that "busy" visual scenes cause a sense of disorientation, nausea, or a "brain fog" that can last long after the stimulus has been removed. This sensitivity is thought to arise from the brain’s inability to properly integrate visual signals with the vestibular signals from the inner ear, leading to a state of sensory overload.
Chronology and Methodology of the UCSF Study
The research project was initiated to bridge the gap between patient-reported distress and clinical measurement. The team, led by Dr. Alexandra T. Bourdillon and including experts in neurotology, radiology, and neurology, designed a protocol that would expose participants to varying degrees of visual motion while monitoring their immediate physiological and symptomatic responses.
The study cohort consisted of 36 participants: 17 individuals diagnosed with vestibular migraine and 19 healthy control subjects with no history of vestibular or neurological disorders. To ensure the highest level of control, the experiment was conducted while participants were positioned inside an MRI scanner. This environment allowed for a consistent field of vision and minimized external distractions that could interfere with the data.
During the sessions, each participant viewed a sequence of 20 short video clips. Each clip lasted 30 seconds and was carefully selected to represent a spectrum of visual motion "intensity." The stimuli ranged from low-motion, calming scenes—such as underwater snorkeling or slow-moving nature vistas—to high-intensity, "high-optic-flow" scenes, such as biking through dense city traffic, skydiving, or rapid first-person movement through complex architecture.
Following each 30-second exposure, participants were asked to rate four key symptoms on a standardized scale:
- Dizziness
- Headache
- Nausea
- Mental fogginess
The researchers then calculated a "composite symptom score" for each participant, representing the cumulative impact of the visual stimuli. This data was subsequently compared to established clinical assessments, including the Dizziness Handicap Inventory (DHI) and the Visual Vertigo Analogue Scale (VVAS), to determine if the experimental results correlated with the patients’ real-world experiences.
Analyzing the Data: Striking Divergence in Symptom Response
The findings of the study revealed a stark contrast between the VM group and the control group. While the healthy participants reported minimal to no distress across the various video clips, the individuals with vestibular migraine experienced significant symptom escalation, particularly when exposed to high-motion scenes.
The composite symptom scores for the VM group were significantly higher than those of the control group across nearly all categories. Notably, the study found that the intensity of the visual motion in the videos directly correlated with the severity of the symptoms reported by VM patients. While low-motion videos produced mild responses, high-optic-flow videos triggered intense bouts of dizziness and nausea.
One of the most significant aspects of the data was the correlation between the experimental scores and existing clinical metrics. The UCSF team found that participants who scored high on the DHI and VVAS—indicating a high level of daily disability due to dizziness—also showed the most severe reactions to the video stimuli in the MRI. This correlation is vital because it validates the use of visual-motion-based assessments as a reflection of a patient’s overall disease burden. It suggests that a standardized "stress test" for the visual system could provide a reliable objective measure of how much the disorder is affecting a patient’s life.
Official Recognition and Scientific Implications
The selection of this study for the VeDA/ANS Travel Award highlights its potential to reshape clinical practice. The award, funded by the Vestibular Disorders Association (VeDA) and the American Neurotology Society (ANS), is specifically designed to support early-career scientists whose work promises to improve the lives of those with vestibular impairments.
By presenting these findings at the Combined Sections Meeting in 2026, the research team has sparked a broader conversation within the medical community regarding the "invisibility" of vestibular symptoms. Dr. Jeffrey D. Sharon, one of the senior authors of the study, has long advocated for better diagnostic clarity in neurotology. The team’s work suggests that by using specific visual triggers, clinicians can move beyond asking "How dizzy do you feel?" to observing "How does your brain process this specific visual challenge?"
The implications of this study extend into the realm of neuroimaging. While the current report focuses on symptom scores, the use of an MRI scanner as the testing environment suggests that future data may reveal how specific regions of the brain—such as the vestibular cortex or the visual processing centers—respond differently in VM patients compared to healthy individuals. This could eventually lead to the identification of biological markers for vestibular migraine, which currently lacks a definitive blood test or imaging-based diagnosis.
Broader Impact on Treatment and Telehealth
The success of using video-based stimuli to provoke and measure symptoms opens new doors for the future of vestibular rehabilitation and remote medicine. Currently, many patients must travel long distances to see a neurotology specialist. The findings from the UCSF study suggest that a "digital diagnostic" tool, consisting of a curated set of videos, could potentially be used in a telehealth setting to assess a patient’s sensitivity to visual motion.
Furthermore, this research has significant implications for Vestibular Rehabilitation Therapy (VRT). VRT often involves habituation exercises where patients are gradually exposed to the very movements that trigger their dizziness. By identifying the specific types of visual motion that cause the greatest distress—whether it is linear motion, rotational motion, or "busy" environments—therapists can create more personalized habituation protocols. Instead of a one-size-fits-all approach, a patient could be assigned a "video prescription" tailored to their specific sensitivity levels.
Addressing Limitations and Looking Toward the Future
While the results are compelling, the researchers acknowledged certain limitations. The sample size of 36 participants is relatively small, and the unique environment of an MRI scanner may not perfectly replicate the experience of walking through a real-world environment. However, the study serves as a successful "proof of concept."
The next phase of research will likely involve determining the minimum number of videos required to reach a diagnostic conclusion. If a five-minute video assessment can provide the same diagnostic value as a longer session, it could be easily integrated into a standard clinic visit. Additionally, expanding the study to include patients with other conditions, such as PPPD or chronic motion sickness, would help determine if these visual sensitivities are unique to vestibular migraine or represent a broader spectrum of sensory processing disorders.
Conclusion: A Step Toward Objective Neurotology
The UCSF study represents a critical advancement in the quest to provide objective evidence for the "invisible" struggles of those with vestibular migraine. By proving that visual vertigo can be measured and quantified through standardized stimuli, the research team has provided a new lens through which to view patient care.
As the medical community continues to integrate these findings, the hope is that patients will no longer have to struggle to explain their symptoms to skeptical providers. Instead, they will have access to assessments that validate their experience and treatments that are precisely calibrated to their needs. The presentation of this research at the 2026 ANS meeting serves as a reminder that the intersection of technology and clinical observation is where the most meaningful progress in patient outcomes is achieved. Through the continued dedication of researchers like the UCSF team, the path toward a more balanced life for those with vestibular disorders is becoming clearer.